These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7861672)

  • 1. Antiallergic effect of ZCR-2060: antihistaminic action.
    Abe T; Omata T; Yoshida K; Matsumura T; Ikeda Y; Segawa Y; Matsuda K; Nagai H
    Jpn J Pharmacol; 1994 Sep; 66(1):87-94. PubMed ID: 7861672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ZCR-2060, an antiallergic agent, on antigen-induced immediate- and late-phase increases in airway resistance in sensitized guinea pigs.
    Abe T; Yoshida K; Omata T; Segawa Y; Matsuda K; Nagai H
    Int Arch Allergy Immunol; 1995 Jan; 106(1):78-85. PubMed ID: 7812169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects.
    Matsushita N; Aritake K; Takada A; Hizue M; Hayashi K; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
    Jpn J Pharmacol; 1998 Sep; 78(1):11-22. PubMed ID: 9804057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiallergic effects of ZCR-2060: effect on allergic cutaneous reactions and rhinitis models in mice and rats.
    Abe T; Omata T; Yoshida K; Segawa Y; Matsuda K; Nagai H
    Jpn J Pharmacol; 1994 Sep; 66(1):95-103. PubMed ID: 7532246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VUF-K-8788, a periphery-selective histamine H1 antagonist with anti-pruritic activities.
    Takizawa T; Matsumoto J; Tohma T; Kanke T; Wada Y; Nagao M; Inagaki N; Nagai H; Zhang MQ; Timmerman H
    Jpn J Pharmacol; 2001 May; 86(1):55-64. PubMed ID: 11430473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological study of ebastine, a novel histamine H1-receptor antagonist].
    Yakuo I; Ishii K; Seto Y; Imano K; Takeyama K; Nakamura H; Karasawa T
    Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):121-35. PubMed ID: 7511558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
    Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
    Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of non-drowsiness after oral administration of TMK688, a novel antiallergic drug.
    Shizawa T; Inaba K; Yoshida F; Iizuka T; Hijikuro K; Yanoshita R; Kamitani T
    Arzneimittelforschung; 1998 Oct; 48(10):979-84. PubMed ID: 9825114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiallergic effects of mequitazine. 1. In vitro experiments].
    Kohno S; Yamamura H; Ohata K; Nagai H; Koda A; Yanagihara Y; Shida T; Masuki S; Yoshida Y; Tatumi H
    Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):145-57. PubMed ID: 2465260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor.
    Kakiuchi M; Ohashi T; Musoh K; Kawamura K; Morikawa K; Kato H
    Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo and in vitro activity of AHR-13268D, a new antiallergic/antihistaminic agent.
    Nolan JC; Foxwell MH; Whitman LL; Johnson DN; Yanni JM; Greene SV
    Agents Actions; 1990 Nov; 31(3-4):210-8. PubMed ID: 1982201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.
    Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
    Drugs R D; 2006; 7(4):219-31. PubMed ID: 16784247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
    Cardell LO; Edvinsson L
    Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators.
    Fukuda T; Morimoto Y; Iemura R; Kawashima T; Tsukamoto G; Ito K
    Arzneimittelforschung; 1984; 34(7):801-5. PubMed ID: 6149754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
    Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of the isolated guinea pig ileum to antihistaminic agents.
    Onnen I; Olive G
    Eur J Pharmacol; 1983 Jun; 90(2-3):185-91. PubMed ID: 6135621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of a novel long-acting histamine H1 receptor antagonist, KAA-276.
    Kobayashi T; Takehana Y; Shinagawa K; Tsuyuki S; Tokutake Y; Sato M; Momose D
    Biol Pharm Bull; 1998 Apr; 21(4):350-5. PubMed ID: 9586571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between central and peripheral antihistamine activities of the new antiallergic agent N-[4-[4-(diphenylmethyl)-1-piperazinyl]-butyl]-3-(6-methyl-3-pyridyl) acrylamide in rats and monkeys.
    Ishii K; Yakuo I; Nakagawa H; Nakamura H
    Arzneimittelforschung; 1993 Jun; 43(6):668-71. PubMed ID: 8102529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.